23/01/2026
Evaluation of Floatation-REST and Anorexia Nervosa
The study The impact of floatation therapy on body image and anxiety in anorexia nervosa investigates whether Floatation-REST can reduce body image disturbance and anxiety in patients with anorexia nervosa receiving inpatient treatment
The study addresses an important clinical problem, as body image disturbance is one of the most persistent and difficult symptoms to treat in anorexia nervosa and often remains even after weight restoration and long-term treatment. There is therefore a clear need for additional treatment approaches that can complement existing care.
The study is designed as a randomized controlled clinical efficacy trial in which participants are assigned either to Floatation-REST in addition to treatment as usual or to treatment as usual alone. This design allows for a structured comparison between standard care and standard care combined with floating, making it possible to evaluate whether Floatation-REST provides additional benefits. Conducting the intervention within an inpatient eating disorder program increases the clinical relevance of the study, as the intervention is tested in a real treatment setting rather than under artificial conditions.
Floatation-REST involves floating on the back in a pool filled with highly concentrated salt water in an environment where sensory stimulation such as light, sound, and movement is minimized. The purpose of this intervention is to reduce physical and psychological stress and to promote deep relaxation. The study is based on the assumption that reduced sensory input may influence bodily perception and emotional regulation, which is particularly relevant for patients with anorexia nervosa who often experience distorted body perception and heightened anxiety. This theoretical rationale is supported by previous research showing that floating can reduce anxiety and stress in both healthy individuals and clinical populations.
An important strength of the study is that it builds on earlier pilot and safety studies that demonstrated that Floatation-REST is well tolerated by individuals with anorexia nervosa. These earlier studies reported no serious adverse events and showed significant reductions in anxiety and body image disturbance following floating sessions. These findings provide a strong justification for further investigation of Floatation-REST in a randomized controlled design and support the ethical and scientific basis of the current study.
The outcome measures used in the study are another clear strength. The primary outcome is change in body image dissatisfaction, measured with the Photographic Figure Rating Scale, which assesses the discrepancy between perceived current body size and ideal body size. This is a clinically meaningful measure that directly reflects the core symptom the intervention aims to influence. In addition, the study includes well-established and validated self-report measures of anxiety, eating disorder symptom severity, and functional impairment. The use of validated instruments strengthens the reliability and credibility of the findings and allows for comparison with previous research in the field.
Measurements are collected repeatedly, including before and after each floating session as well as at follow-up assessments six weeks and six months after the intervention. This design makes it possible to examine both short-term and longer-term effects of Floatation-REST. The inclusion of follow-up assessments is particularly valuable, as it allows the study to explore whether potential improvements persist beyond the immediate intervention period.
Safety considerations are carefully addressed throughout the study. Given the medical and psychological vulnerability of patients with anorexia nervosa, the study includes clear inclusion and exclusion criteria to minimize risk. Participants are regularly monitored for vital signs, and there are detailed procedures for identifying, reporting, and managing adverse events. Floatation-REST is a non-pharmacological intervention that can be stopped at any time by the participant, which further enhances its safety profile. Previous safety data referenced in the study protocol also support the conclusion that floating does not pose significant medical risks when applied under controlled conditions.
Another positive aspect of the study is that Floatation-REST is presented as a complementary intervention rather than a replacement for established treatment. This approach is clinically appropriate, as anorexia nervosa is a complex disorder that requires multimodal treatment. Floating is framed as a potential tool to target specific symptoms—particularly body image disturbance and anxiety—that often remain difficult to treat using conventional approaches alone.
In summary, the study presents Floatation-REST as a well-motivated, safe, and feasible intervention for patients with anorexia nervosa in inpatient care. The randomized controlled design, strong theoretical rationale, use of validated outcome measures, and thorough attention to safety all support a positive evaluation of floating based on what the study shows. The protocol provides a solid foundation for further research and suggests that Floatation-REST has meaningful potential as a valuable complement to existing treatments within specialized eating disorder care.